Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Gains from Investment Securities (2016 - 2025)

Neuroone Medical Technologies' Gains from Investment Securities history spans 8 years, with the latest figure at $4806.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 95.71% year-over-year to $4806.0; the TTM value through Dec 2025 reached $4806.0, down 35.71%, while the annual FY2025 figure was $6.1 million, 396.31% up from the prior year.
  • Gains from Investment Securities reached $4806.0 in Q4 2025 per NMTC's latest filing, up from $2771.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.2 million in Q1 2024 to a low of -$319625.0 in Q2 2025.
  • Average Gains from Investment Securities over 5 years is $72520.1, with a median of -$5091.5 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: crashed 105.88% in 2022, then skyrocketed 2058.59% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$26235.0 in 2021, then soared by 471.78% to $97536.0 in 2022, then tumbled by 86.1% to $13559.0 in 2023, then skyrocketed by 725.27% to $111898.0 in 2024, then tumbled by 95.71% to $4806.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Gains from Investment Securities are $4806.0 (Q4 2025), $2771.0 (Q3 2025), and -$319625.0 (Q2 2025).